Table 1.
Treatment | LVEDP (mmHg) | LVESP (mmHg) | dP/dtmax (mmHg/s) | dP/dtmin (mmHg/s) |
---|---|---|---|---|
Control | 5.22 ± 0.24 | 87.13 ± 0.69 | 2798 ± 64 | −2259 ± 60 |
BPA | 5.24 ± 0.43 | 87.76 ± 2.42 | 2785 ± 79 | −2238 ± 42 |
BPS | 4.93 ± 0.33 | 89.00 ± 1.37 | 2788 ± 41 | −2314 ± 36 |
BPS + PHTTP | 5.01 ± 0.23 | 90.61 ± 2.49 | 2944 ± 96 | −2481 ± 81 |
Key: LVEDP, left ventricular end diastolic pressure; LVESP, left ventricular end systolic pressure; dP/dtmax, maximum rate of contraction; dP/dtmin, maximum rate of relaxation; BPA, bisphenol A (1 nM); BPS, bisphenol S (1 nM); PHTPP, estrogen receptor-β anatagonist (1 μM). N = 10 for all groups except N = 6 for BPS + PHTPP. Values presented are mean ± SEM.